These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 28295312

  • 1. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.
    Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC, MTA Cooperative Group.
    J Child Psychol Psychiatry; 2017 Jun; 58(6):663-678. PubMed ID: 28295312
    [Abstract] [Full Text] [Related]

  • 2. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.
    Greenhill LL, Swanson JM, Hechtman L, Waxmonsky J, Arnold LE, Molina BSG, Hinshaw SP, Jensen PS, Abikoff HB, Wigal T, Stehli A, Howard A, Hermanussen M, Hanć T, MTA Cooperative Group.
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):978-989. PubMed ID: 31421233
    [Abstract] [Full Text] [Related]

  • 3. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results.
    Hechtman L, Swanson JM, Sibley MH, Stehli A, Owens EB, Mitchell JT, Arnold LE, Molina BS, Hinshaw SP, Jensen PS, Abikoff HB, Perez Algorta G, Howard AL, Hoza B, Etcovitch J, Houssais S, Lakes KD, Nichols JQ, MTA Cooperative Group.
    J Am Acad Child Adolesc Psychiatry; 2016 Nov; 55(11):945-952.e2. PubMed ID: 27806862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
    Lam AP, Matthies S, Graf E, Colla M, Jacob C, Sobanski E, Alm B, Rösler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Müller HHO, Lücke C, Huss M, Jans T, Berger M, Tebartz van Elst L, Philipsen A, Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium.
    JAMA Netw Open; 2019 May 03; 2(5):e194980. PubMed ID: 31150084
    [Abstract] [Full Text] [Related]

  • 8. Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA.
    Roy A, Hechtman L, Arnold LE, Sibley MH, Molina BS, Swanson JM, Howard AL, MTA Cooperative Group.
    J Am Acad Child Adolesc Psychiatry; 2016 Nov 03; 55(11):937-944.e4. PubMed ID: 27806861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency.
    Howard AL, Molina BS, Swanson JM, Hinshaw SP, Belendiuk KA, Harty SC, Arnold LE, Abikoff HB, Hechtman L, Stehli A, Greenhill LL, Newcorn JH, Wigal T.
    Addiction; 2015 May 03; 110(5):784-95. PubMed ID: 25664657
    [Abstract] [Full Text] [Related]

  • 14. Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study.
    Molina BSG, Howard AL, Swanson JM, Stehli A, Mitchell JT, Kennedy TM, Epstein JN, Arnold LE, Hechtman L, Vitiello B, Hoza B.
    J Child Psychol Psychiatry; 2018 Jun 03; 59(6):692-702. PubMed ID: 29315559
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
    Arch Gen Psychiatry; 1999 Dec 03; 56(12):1073-86. PubMed ID: 10591283
    [Abstract] [Full Text] [Related]

  • 17. Risk for emerging bipolar disorder, variants, and symptoms in children with attention deficit hyperactivity disorder, now grown up.
    Elmaadawi AZ, Jensen PS, Arnold LE, Molina BS, Hechtman L, Abikoff HB, Hinshaw SP, Newcorn JH, Greenhill LL, Swanson JM, Galanter CA.
    World J Psychiatry; 2015 Dec 22; 5(4):412-24. PubMed ID: 26740933
    [Abstract] [Full Text] [Related]

  • 18. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A, Hull JT, Chaturvedi SA, Liranso T, Odebo O, Kosheleff AR, Fry N, Cutler AJ, Rubin J, Schwabe S, Childress A.
    CNS Drugs; 2022 Aug 22; 36(8):897-915. PubMed ID: 35896943
    [Abstract] [Full Text] [Related]

  • 19. ADHD, stimulant treatment, and growth: a longitudinal study.
    Harstad EB, Weaver AL, Katusic SK, Colligan RC, Kumar S, Chan E, Voigt RG, Barbaresi WJ.
    Pediatrics; 2014 Oct 22; 134(4):e935-44. PubMed ID: 25180281
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.